Indication
RZV Vaccine (Shingrix)
1 clinical trial
1 product
Clinical trial
Immune Response to the Recombinant Zoster Vaccine in People Living With HIV Over 50 Years of Age Compared to Non-HIV Age- and Gender-matched Controls - The Shingr'HIV Phase IV Multicenter StudyStatus: Recruiting, Estimated PCD: 2024-09-30
Product
Recombinant Zoster Vaccine